logo

BCYC

Bicycle Therapeutics·NASDAQ
--
--(--)
--
--(--)

BCYC fundamentals

Bicycle Therapeutics (BCYC) released its earnings on Aug 8, 2025: revenue was 2.92M (YoY -68.81%), missed estimates; EPS was -1.14 (YoY -48.05%), missed estimates.
Revenue / YoY
2.92M
-68.81%
EPS / YoY
-1.14
-48.05%
Report date
Aug 8, 2025

Earnings

EPS
Revenue

Revenue & Expenses

BCYC has released its 2025 Q4 earnings report, with revenue of 47.95M, reflecting a YoY change of 1193.28%, and net profit of -20.15M, showing a YoY change of 61.13%. The Sankey diagram below clearly presents BCYC's revenue sources and cost distribution.

Key Indicators

Bicycle Therapeutics (BCYC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Bicycle Therapeutics (BCYC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Bicycle Therapeutics (BCYC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Bicycle Therapeutics (BCYC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Bicycle Therapeutics (BCYC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Bicycle Therapeutics (BCYC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield